Volume 7, Issue 2 (7-2019)                   Jorjani Biomed J 2019, 7(2): 31-38 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fozouni L, Yaghoobpour M, Ahani Azari A. Probiotics in Goat Milk: A Promising Solution for Management of Drug-Resistant Acinetobacter baumannii. Jorjani Biomed J. 2019; 7 (2) :31-38
URL: http://goums.ac.ir/jorjanijournal/article-1-656-en.html
1- Department of Biology, Gorgan Branch, Islamic Azad University, Gorgan, Iran , lili_kia@yahoo.com
2- Department of Biology, Gorgan Branch, Islamic Azad University, Gorgan, Iran
Abstract:   (824 Views)
 Background and objectives: Acinetobacter is a genus of opportunistic pathogens that are commonly found in the environment. Given the unique ability of these bacteria to survive in the hospital, they are considered as one of the main causes of hospital-acquired infections. The emergence of multidrug-resistant Acinetobacter spp., particularly Acinetobacter baumannii has become a major health threat worldwide. In this study, we investigate antibacterial effects of probiotic isolates from goat milk on clinical isolates of A. baumannii.
Methods: In this study, 100 clinical specimens were taken from patients hospitalized in six hospitals in the Golestan Province, north of Iran. Following isolation and identification of A. baumannii strains, antibiotic resistance patterns of the isolates were investigated using the Kirby-Bauer method according to the Clinical and Laboratory Standards Institute (CLSI-2015) guidelines. Probiotic bacteria in goat milk were isolated and identified by culture in MRS and M17 media and carbohydrate fermentation tests. Antibacterial effects of the probiotic bacteria against resistant A. baumannii isolates were evaluated using the agar well diffusion method.
Results: Overall, 55% of the isolates were identified as A. baumannii. The highest resistance rates were observed against tobramycin (76.3%), mezlocillin (74.5%) and cefotaxime (74.5%). Resistance to levofloxacin, tetracycline, imipenem and minocycline was detected in 72.7%, 72.7%, 70.9% and 29.1% of the isolates, respectively. The most common probiotic isolates were Lactobacillus plantarum and Lactococcus piscium (30% each). The highest and lowest effects were exerted by Lactococcus lactis (34.54%) and Lactobacillus bulgaricus (3.63%), respectively.
Conclusion: Our results demonstrate that the prevalence of drug-resistant A. baumannii strains is high in the hospitals. Given the promising antimicrobial effects of the isolated probiotic bacteria, goat milk can be recommended as an adjuvant therapy or an alternative to common antibiotics for improving treatment outcome of infections caused by drug-resistant A. baumannii.
Full-Text [PDF 417 kb]   (172 Downloads)    
Type of Article: Original article | Subject: Health
Received: 2019/08/4 | Revised: 2020/01/27 | Accepted: 2019/09/1

1. Curtis LT. Prevention of Hospital Acquired Re view of Non-Pharmacological Intervention. JHosp Infect.2008; 69(3):204-219. [DOI] [Google Scholar]
2. Eveillard M, Kempf M, Belmonte O, Pailhoriès H, Joly-Guillou ML. Reservoirs of Acinetobacterbaumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int Journal Infect Dis.2013; 17)10 (:802-805. [DOI] [Google Scholar]
3. Tang SS,Apisarnthanarak A, Hsu LY. Mechanisms of B-lactam antimicrobial resistance and epidemiology of major community and healthcare-associated multidrug-resistant bacteria.Adv DrugDelivRev.2014; 7: 3-13. [DOI] [Google Scholar]
4. Kim Uj, Kim Hk, An JH, Cho SK, Park Kh, Jang HC. Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections.chonnam Med Journal.2014; 50)2(:37-44. [DOI] [Google Scholar]
5. Nhu NTK, Lan NPH, Campbell JI, Parry CM, Thompson C, Tuyen HT, Howamg MVM, et al. Emergence of carbapenem-resistant Acinetobacterbaumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. Journal Med Microbial.2014; 63)10(:1386-1394. [DOI] [Google Scholar]
6. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother.2006; 50(9): 2946-2950. [DOI] [Google Scholar]
7. Garcia-Quintanilla M, Pulido MR, Lopez-Roja R, Pachon J, McConnell MJ. Emerging therapies for multidrug resistant Acinetobacterbaumannii. Trends Microbial. 2013;21(3):157-163. [DOI] [Google Scholar]
8. Oh Y.J, Song SH, Baik SH, Lee HH, Han IM, Oh DH. A case of fulminant community-acquired Acinetobacterbaumannii pneumonia in Korea.Korean Journal Intern Med. 2013;28)4(:486-490. [DOI] [Google Scholar]
9. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease : underscoring the importance of viability. Journal Pediatr Gastroenterol Nutr.2003; 36(2): 223-227. [DOI] [Google Scholar]
10. Carvalho Eunice B, Maga Elizabeth A, Quetz Josiane S,Lima Ila FN, Magalhaes Hemerson YF, et al. Goat Milk With and Without Increased Concentrations of Lysozyme Improves Repair of Intesyinal Cell Damage Induced by Enteroaggregative Escherichia Coli. BMC Gastroenterol.2012; 12:106. [DOI] [Google Scholar]
11. Performance Standards for Antimicrobial SusceptibilityTesting; Twenty-Fifth Informational Supplement. M100-S25.Wayne, PA.2015; 3(35):56-58.
12. Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, et al. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPCcarbapenemases in Enterobacteriaceae clinical isolates. Journal Antimicrob Chemother.2010; 65(8): 1664-1671. [DOI] [Google Scholar]
13. Jafari S, Najafipour S, Kargar M, Abdollahi A, Mardaneh J, Fasihy Ramandy M, et al. Phenotypical Evaluation of Multi-Drug Resistant Acinetobacter Baumannii. J Fasa Univ Med Sci. 2013; 2 (4) :254-258. [Google Scholar]
14. Nourmohammadi Z, Zamanzad B, Shavarzi A, Kiani P. Evaluation antimicrobial resistance of Acinetobacter baumannii isolated from shahrekord teaching hospitals in 2013. Journal Shahrekord Univ Med Sci. 2015; 16(6): 1-8. [Google Scholar]
15. Moradi J, Hashemi Farhad B, Bahador A. Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature. Osong Public Health Res Perspect. 2015; 6(2): 79-86. [DOI] [Google Scholar]
16. Lei Gao, Yuan Lyu, and Yun Li. Trends in Drug Resistance of Acinetobacter baumannii over a 10-year period: Nationwide Data from the China Surveillance of Antimicrobial Resistance program. Chin Med Journal.2017; 130(6): 659-664. [DOI] [Google Scholar]
17. Badis A, Guetarni D, Moussa Boudjema B, Henni D.E, Kihal M. Identification and Technological properties of lactic acid bacteria isolated from raw goat milk of four Algerian races. Food Microbiology.2004; 21(5): 579-588. [DOI] [Google Scholar]
18. Mithun S, Dipak V, Sheela S. Isolation and Identification of lactobacilli from raw milk samples obtained from Aarey Milk Colony. International Journal of Scientific and Research Publications. 2015 Apr;5(4):1-5. [Google Scholar]
19. Oscar F. Hernández-Saldaña, Mauricio Valencia-Posadas, Norma M. de la Fuente-Salcido, Dennis K. Bideshi, and José E. Barboza-Corona. Bacteriocinogenic Bacteria Isolated from Raw Goat Milk and Cheese Produced in the Center of Mexico. Indian J Microbiol.2016;56(3):301-308. [DOI] [Google Scholar]
20. Savadogo A, Ouattra CA, Bassole IHN, Traore AS. Antimicrobial activities of lactic acid bacteria strains isolated from Burkina faso fermented milk. Pakistan Journal of nutrition.2004; 3 (3):174-179. [DOI] [Google Scholar]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Jorjani Biomedicine Journal

Designed & Developed by : Yektaweb